NR4A1 and breast carcinoma: Coumarin-monastrol hybrids (compound 62) have also been designed and synthetized, and further evaluated against both hormone receptor (positive and negative) breast cancers, which selectively induce apoptosis in both primary and metastatic breast cancer cell lines [146].